EB-005

N/A

Report date: 2025/08/15 17:43:04

Base Information

Drug NameEB-005
Drug Alias NameEB-005
ClassificationBiologics > BacteriophagesCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionDNA inhibitorsCell death stimulants
TargetsDNA
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEligo Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcEligo Bioscience
Inactive CompaniesN/A
Active IndicationsAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A